Clinical Trial

OnabotulinumtoxinA for Trigeminal Neuralgia

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
A randomized controlled trial comparing Onabotulinumtoxin A to saline (placebo) for Trigeminal Neuralgia.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-01-11; most recent amendment 2026-01-20.
Status change: Not Yet Recruiting → Recruiting 2024-06-14
Trial Details
NCT Number NCT06216886
Lead Sponsor Stanford University
Conditions Trigeminal Neuralgia
Enrollment 20 participants
Start Date 2024-06-01
Primary Completion 2027-02-01 (estimated)
Study Completion 2027-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-22